while the 36-month beta value is -1.68.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for CMND is 12.93M, and currently, short sellers hold a 2.49% ratio of that floaft. The average trading volume of CMND on November 21, 2023 was 2.04M shares.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
CMND) stock’s latest price update
Clearmind Medicine Inc (NASDAQ: CMND) has experienced a decline in its stock price by -8.39 compared to its previous closing price of 0.13. However, the company has seen a fall of -13.14% in its stock price over the last five trading days. GlobeNewsWire reported 2023-10-05 that Tel Aviv, Israel / Vancouver, Canada, Oct. 05, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the “company”), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced that Dr. Adi Zuloff-Shani, CEO of Clearmind Medicine, will be participating in the 8th Annual Dawson James Conference on Thursday, October 12th, 2023, at the Wyndam Grand Jupiter at Harbourside Place, in Jupiter Florida.
CMND’s Market Performance
Clearmind Medicine Inc (CMND) has seen a -13.14% fall in stock performance for the week, with a -18.04% decline in the past month and a -72.26% plunge in the past quarter. The volatility ratio for the week is 14.70%, and the volatility levels for the past 30 days are at 12.76% for CMND. The simple moving average for the past 20 days is -11.97% for CMND’s stock, with a -87.61% simple moving average for the past 200 days.
CMND Trading at -29.40% from the 50-Day Moving Average
After a stumble in the market that brought CMND to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -98.05% of loss for the given period.
Volatility was left at 12.76%, however, over the last 30 days, the volatility rate increased by 14.70%, as shares sank -17.58% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -70.44% lower at present.
During the last 5 trading sessions, CMND fell by -12.41%, which changed the moving average for the period of 200-days by -96.76% in comparison to the 20-day moving average, which settled at $0.1339. In addition, Clearmind Medicine Inc saw -96.23% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for CMND
The total capital return value is set at -510.22, while invested capital returns managed to touch -571.69. Equity return is now at value -390.19, with -225.51 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 0.22.
Conclusion
In a nutshell, Clearmind Medicine Inc (CMND) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
